Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Le GM, Gomez SL, Clarke CA, Glaser SL, West DW. Cancer incidence patterns among Vietnamese in the United States and Ha Noi, Vietnam. Int J Cancer 2002;102:412–7.
   PubMed Web of Science ®Google Scholar
• Lin SS, Phan JC, Lin AY. Breast cancer characteristics of Vietnamese women in the Greater San Francisco Bay Area. West J Med 2002;176:87–91.
   PubMedGoogle Scholar
• Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases. Cancer 1996;77:1465–71.
   PubMed Web of Science ®Google Scholar
• Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: A systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004;13:1558–68.
   PubMed Web of Science ®Google Scholar
• Gown AM. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 2008;21(Suppl 2):S8–15.
   PubMed Web of Science ®Google Scholar
• Miller BA, Hankey BF, Thomas TL. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 2002;155:534–45.
   PubMed Web of Science ®Google Scholar
• Pegoraro RJ, Karnan V, Nirmul D, Joubert SM. Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 1986;46(4 Pt 2):2117–20.
   PubMedGoogle Scholar
• Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005;16:1569–83.
   PubMed Web of Science ®Google Scholar
• Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, . American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25:5287–312.
   PubMed Web of Science ®Google Scholar
• Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, . Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol 2002;20:2559–66.
   PubMed Web of Science ®Google Scholar
• Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M, . Tumor markers in breast cancer – European Group on Tumor Markers recommendations. Tumour Biol 2005;26:281–93.
   PubMed Web of Science ®Google Scholar
• Lofgren L, Skoog L, von Schoultz E, Tani E, Isaksson E, Fernstad R, . Hormone receptor status in breast cancer – a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 2003;14:136–42.
   PubMedGoogle Scholar
• Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 2002;11:601–7.
   PubMed Web of Science ®Google Scholar
• Lertsanguansinchai P, Chottetanaprasith T, Chatamra K, Sampatanukul P, Wannakrairot P, Rojpornpradit P, . Estrogen and progesterone receptors status in Thai female breast cancer patients: An analysis of 399 cases at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2002;85(Suppl 1):S193–202.
   Google Scholar
• Leong BD, Chuah JA, Kumar VM, Yip CH. Breast cancer in Sabah, Malaysia: A two year prospective study. Asian Pac J Cancer Prev 2007;8:525–9.
   PubMedGoogle Scholar
• Chow LW, Ho P. Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol 2000;75:172–5.
   PubMed Web of Science ®Google Scholar
• Ferno M, Borg A, Johansson U, Norgren A, Olsson H, Ryden S, . Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group. Acta Oncol 1990;29:129–35.
   PubMed Web of Science ®Google Scholar
• Tran D, Lawson J. Rates of estrogen receptor-alpha expression are no different in low-risk (Vietnam) and high-risk (Australian) breast cancer. Appl Immunohistochem Mol Morphol 2004;12:139–41.
   PubMedGoogle Scholar
• Choi DH, Shin DB, Lee MH, Lee DW, Dhandapani D, Carter D, . A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer 2003;98: 1587–95.
   PubMedGoogle Scholar
• Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000;88:114–23.
   PubMed Web of Science ®Google Scholar
• Oyama T, Ishikawa Y, Hayashi M, Arihiro K, Horiguchi J. The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer 2007;14:182–8.
   PubMedGoogle Scholar
• Allred DC. Problems and solutions in the evaluation of hormone receptors in breast cancer. J Clin Oncol 2008;26: 2433–5.
   PubMedGoogle Scholar
• Arihiro K, Umemura S, Kurosumi M, Moriya T, Oyama T, Yamashita H, . Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol 2007;127:356–65.
   PubMed Web of Science ®Google Scholar
• Khoshnoud M, Fohlin H, Fornander T, Stål O, Skoog L, Bergh J, . Immunohistochemistry compared to cytosol assay for determination of estrogen receptor and prediction of long term effect of adjuvant tamoxifen. Forthcoming.
   Google Scholar
• Ferrero-Pous M, Trassard M, Le Doussal V, Hacene K, Tubiana-Hulin M, Spyratos F. Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients. Appl Immunohistochem Mol Morphol 2001;9:267–75.
   PubMedGoogle Scholar